Publications

Thompson CM, Fedorov Y, Brown DD, Suh M, Proctor DM, Kuriakose L, Haws L, Harris MA. 2012. Assessment of Cr(VI)-induced cytotoxicity and genotoxicity using high content analysis. PLoS One 7(8):e42720; doi: 10.1371/journal.pone.0042720. PMID: 22905163.

Wheeler MW, Bailer AJ. 2012. Monotonic Bayesian semiparametric benchmark dose analysis. Risk Anal 32(7):1207-18; doi: 10.1111/j.1539-6924.2011.01786.x. PMID: 22385024.

Kopec AK, Thompson CM, Kim S, Forgacs AL, Zacharewski TR. 2012. Comparative toxicogenomic analysis of oral Cr(VI) exposure effects in rat and mouse small intestinal epithelium. Toxicol Appl Pharmacol 262(2):124-138; doi: 10.1016/j.taap.2012.04.026. PMID: 22561333.

Lamb DJ, Parker N, Ulrich K, Walsh R, Yeadon M, Evans SM. 2012. Characterisation of a mouse model of cigarette smoke extract-induced lung inflammation. J Pulmon Resp Med 2(3); doi: 10.4172/2161-105X.1000125.

Phelka AD, Finley BL. 2012. Potential health hazards associated with exposures to asbestos-containing drywall accessory products: A state-of-the-science assessment. Crit Rev Toxicol 42(1):1–27; doi: 10.3109/10408444.2011.613067. PMID: 22044019.

Unice KM, Monnot AD, Gaffney SH, Tvermoes BE, Thuett KA, Paustenbach DJ, Finley BL. 2012. Inorganic cobalt supplementation: Prediction of cobalt levels in whole blood and urine using a biokinetic model. Food Chem Toxicol 50(7):2456–2461; doi: 10.106/j.fct.2012.04.009. PMID: 22538081.

Finley BL, Pierce JS, Paustenbach DJ, Scott LLF, Lievense L, Scott PK, Galbraith DA. 2012. Malignant pleural mesothelioma in U.S. automotive mechanics: Reported vs. expected number of cases from 1975-2007. Regul Toxicol Pharmacol 64(1):14–116; doi: 10.1016/j.yrtph.2012.05.015. PMID: 22668748.

Knutsen JS, Kerger BD, Finley BL, Paustenbach DJ. 2012. A calibrated human PBPK model for benzene inhalation with urinary bladder and bone marrow compartments. Risk Anal 33 (7):1237–1251; doi: 10.1111/j.1539-6924.2012.01927.x. PMID: 23278103.

Finley BL, Pierce JS, Phelka AD, Adams RE, Paustenbach DJ, Thuett KA, Barlow CA. 2012. Evaluation of tremolite asbestos exposures associated with the use of commercial products. Crit Rev Toxicol 42(2):119–146; doi: 10.3109/10408444.2011.636028. PMID: 22141364.

Finley BL, Monnot AD, Paustenbach DJ, Gaffney SH. 2012. Derivation of a chronic reference dose for cobalt. Regul Toxicol Pharmacol 64(3):491–503; doi: 10.1016/j.yrtph.2012.08.022. PMID: 22982439.

Mwanza JC, Lyke DF, Hertzberg RC, Haber L, Kohrman-Vincent M, Li R, et al. 2012. Cholinesterase inhibition and depression of the photic after discharge flash evoked potentials following acute or repeated exposures to a mixture of carbaryl and propoxur. Neurotoxicol 33(3):332–346; 10.1016/j.neuro.2012.02.006. PMID: 22353443.

Fowler, JC, Bhattacharya S, Urban JD, Vaidehi N, Mailman RB. 2012. Receptor conformations involved in dopamine D2L receptor functional selectivity induced by selected transmembrane 5 serine mutations. Mol Pharmacol 81(6):820-831; doi: 10.1124/mol.111.075457. PMID: 22416052.

Henderson RG, Cappellini D, Seilkop SK, Bates HK, Oller AR. 2012. Oral bioaccessibility testing and read-across hazard assessment of nickel compounds. Regul Toxicol Pharmacol 63(1):20-28; doi: 10.1016/j.yrtph.2012.02.005. PMID: 22369872.

Fillos D, Scott LLF, Anderle De Sylor M, Grespin M, Luksemburg WJ, Finley B. 2012. PCB concentrations in shrimp from major import markets and the United States. Environ Toxicol Chem 31(5):1063–1071; doi: 10.1002/etc.1803. PMID: 22407850.

Hinerman JM, Dignam JD, Mueser T. 2012. Models for the binary complex of bacteriophage T4 Gp59 helicase loading protein: G32 single-stranded DNA-binding protein and ternary complex with pseudo-Y junction DNA. J Biol Chem 287(22):8608–8617; doi: 10.1074/jbc.M111.333476. PMID: 22493434.

Mease K, Sane RS, Podila L, Taub ME. 2012. Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK-MDR1 monolayers: A strategy to assess the interaction of a new chemical entity with P-gp, BCRP and MRP2. J Pharm Sci 101(5):1888–1897; doi: 10.1002/jps.23069. PMID: 22359351.

Maier A, Kohrman-Vincent M, Hertzberg R, Allen B, Haber LT, Dourson M. 2012. Critical review of dose-response options for F344 rat mammary tumors for acrylamide – Additional insights based on mode of action. Food Chem Toxicol 50(5):1763–1776; doi: 10.1016/j.fct.2012.02.002. PMID: 22366097.

Wang A, Halbert RJ, Baerwaldt T, Nordyke RJ. 2012. U.S. payer perspectives on evidence for formulary decision-making. J Oncol Pract 8(3 Suppl):22s-27s; doi: 10.1200/JOP.2011.000526. PMID: 22942820.

Dobo KL, Greene N, Fred C, Glowienke S, Harvey JS, Hasselgren C, Jolly R, Kenyon MO, et al. 2012. In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: An industry survey. Regul Toxicol Pharmacol 62(3):449-455; doi: 10.1016/j.yrtph.2012.01.007. PMID: 22321701.